Ophthalmic Market Intelligence
Michael E. Lachman

Michael Lachman brings thirty years of experience in medical technology,
including consulting, investment research, business development, marketing,
and engineering. His active involvement in the ophthalmology sector spans
nearly twenty years.

Before launching EyeQ Research in 2005, Michael was a Partner, Managing
Director, and equity research analyst with ThinkEquity Partners, a
growth-focused investment bank based in San Francisco. At ThinkEquity,
Michael's research was focused primarily on ophthalmic devices and
pharmaceuticals, orthopedics, and specialty cardiology. Before that, Michael
was a healthcare analyst on the buy-side with SAC Capital Advisors and Jurika
& Voyles. His first experience in equity research was as a medical device
analyst with Hambrecht & Quist, where he received a #1 ranking in medical
industry stock picking in the Wall Street Journal All-Star Analyst Survey.

Michael also brings twelve years of medical device industry experience. He
worked for five years in business development for the Ethicon Endo-Surgery
division of Johnson & Johnson. Previously, Michael spent seven years with
Baxter Healthcare Corporation, working in both research & development and
product management, with a focus on implantable surgical products.

Michael holds an M.B.A. (with concentrations in marketing and finance) from
Northwestern University's Kellogg School of Management. He also holds an
M.S. in Mechanical Engineering from Stanford University. Michael received a
B.S. in Aeronautical Engineering with highest honors from the University of
Illinois.

E-mail:
michael@lachmanconsulting.com




Copyright ©2005-2015 EyeQ Research/Lachman Consulting LLC. All rights reserved.